Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Lal Path Labs has informed the exchanges about a scheduled analyst and institutional investor meeting on May 20, 2026. The meeting is part of the Centrum Investor Conference and will be held virtually as a group or one-on-one meeting. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting. The filing notes that the meeting date may be subject to change due to exigencies on either party's end.
This is a routine regulatory disclosure with neutral impact on the stock. It reflects normal investor relations activity and transparency but contains no material information. Shareholders can monitor for any follow-up disclosures after the meeting.